Amyloid beta (Aβ) deposits and hyperphosphorylated tau (p-tau) accumulation have been identified in the retina of Alzheimer’s disease (AD) patients and transgenic AD mice. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.